Has Kenneth Staggs received payments from drug or device companies?

Yes. Drug and device makers reported $5,357 in general payments to Kenneth Staggs across 124 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kenneth Staggs did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kenneth Staggs come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kenneth Staggs

Interventional Pain Medicine · Meridian, MSNPI 1043204654

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 77.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2021 at $2,267 and has fallen 99.1% since, to $21 in 2024.

$5,357in general payments, 2019–2025

Across 124 payments — averaging $43.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$4K
Boston Scientific$739
Medtronic$105
Collegium Pharmaceutical, Inc.$60
Foundation Fusion Solutions, LLC$57
Takeda Pharmaceuticals U.S.A., Inc.$37
plus $200 from 11 others

What the payments were for

Food & beverage$5,357100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	78	$4,159
Boston Scientific	19	$739
Medtronic(2 entities)	4	$105
Collegium Pharmaceutical, Inc.	4	$60
Foundation Fusion Solutions, LLC	1	$57
Takeda Pharmaceuticals U.S.A., Inc.	3	$37
Teva Pharmaceuticals USA, Inc.	2	$30
Biodelivery Sciences International, Inc.	2	$28
Radius Health, Inc.	2	$26
Scilex Pharmaceuticals Inc.	2	$24
AstraZeneca	1	$21
GRT US Holding, Inc.	1	$13
Amgen	1	$12
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$12
Vertiflex, Inc.	1	$12
MDD US Operations, LLC	1	$11
Lilly USA, LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,357 in reported general payments places this provider in the 80th percentile of 24 interventional pain medicine providers in Mississippi.

See all interventional pain medicine providers in Mississippi →

Other interventional pain medicine in Meridian

Eric PearsonMeridian$19K
Charles MartinMeridian$18K
Carol HarrisMeridian$4K
Leonel VanceMadison$21K
Matthew BlanchardGulfport$10K
Madelyn CraigMadison$5K
John LutzJackson$5K
Michael SteuerSouthaven$4K
Kelly ColemanVancleave$4K
Thomas YearwoodPascagoula$3K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →